Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Receives Consensus Recommendation of “Buy” from Analysts

Shares of Reckitt Benckiser Group plc (OTCMKTS:RBGLY) have been assigned an average rating of “Buy” from the eight research firms that are covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating, one has issued a buy rating and four have given a strong buy rating to the company.

RBGLY has been the subject of several research reports. UBS Group upgraded Reckitt Benckiser Group to a “strong-buy” rating in a research report on Wednesday, September 18th. Barclays upgraded Reckitt Benckiser Group to a “strong-buy” rating in a research report on Friday, October 4th. Hsbc Global Res raised shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, December 11th. Sanford C. Bernstein lowered shares of Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a report on Monday, November 4th. Finally, HSBC upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a report on Wednesday, December 11th.

Reckitt Benckiser Group Trading Up 0.5 %

Shares of RBGLY opened at $12.03 on Wednesday. Reckitt Benckiser Group has a 12-month low of $10.24 and a 12-month high of $15.03. The company has a debt-to-equity ratio of 0.97, a quick ratio of 0.47 and a current ratio of 0.69. The company has a 50-day moving average of $12.22 and a two-hundred day moving average of $11.83.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.